|
Index of reports
> Disability (19)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erbitux (Cetuximab) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Erbitux side effects in 73 year old male
Reported by a consumer/non-health professional from Germany on 2012-08-16
Patient: 73 year old male, weighing 91.0 kg (200.2 pounds)
Reactions: Amaurosis, Rash, Iritis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Erbitux
Other drugs received by patient: Pregabalin; Doxycycline HCL; Dexamethasone; Leucovorin Calcium; Fluorouracil; Flupirtine Maleate; Laxans; Glimepiride; Morphine Sulfate
Possible Erbitux side effects in 69 year old male
Reported by a physician from Japan on 2012-06-27
Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)
Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Fluorouracil
Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Oxaliplatin
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Erbitux
Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-03-05
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Possible Erbitux side effects in 47 year old male
Reported by a consumer/non-health professional from United States on 2012-06-08
Patient: 47 year old male, weighing 56.0 kg (123.2 pounds)
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Rash
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Erbitux
Dosage: interrrupt on 23feb21.day 1 of cycle 1 only restat on 18apr2012
Indication: Head and Neck Cancer
Start date: 2012-02-23
End date: 2012-05-17
Cisplatin
Dosage: day 1
Indication: Head and Neck Cancer
Start date: 2012-02-23
Fluorouracil
Dosage: days 1-4
Indication: Head and Neck Cancer
Start date: 2012-02-23
Possible Erbitux side effects in 69 year old male
Reported by a consumer/non-health professional from Japan on 2012-06-08
Patient: 69 year old male, weighing 49.0 kg (107.8 pounds)
Reactions: Paronychia, Dysgeusia, Stomatitis, Diarrhoea, Acne, Decreased Appetite
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Leucovorin Calcium
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Erbitux
Dosage: 12mar-2apr12 dose reduced to 375mg recent inf 2apr12
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-03-05
Oxaliplatin
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Fluorouracil
Dosage: iv bolus 19mar-2apr12-600mg 1in2wk
Indication: Colon Cancer
Start date: 2012-03-05
End date: 2012-04-02
Possible Erbitux side effects in
Reported by a physician from Germany on 2012-05-31
Patient:
Reactions: Confusional State, Motor Dysfunction, Cognitive Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Erbitux
Other drugs received by patient: Irinotecan HCL; Trimeton
Possible Erbitux side effects in
Reported by a physician from Germany on 2012-05-28
Patient:
Reactions: Mucosal Inflammation, Diarrhoea, Rash, Thrombocytopenia
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Erbitux
Other drugs received by patient: Fluorouracil; Leucovorin Calcium; Eloxatin
Possible Erbitux side effects in male
Reported by a physician from Japan on 2012-04-20
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Jaundice, Bile Duct Stenosis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Irinotecan Hydrochloride
Dosage: dosage is uncertain.
Indication: Rectal Cancer Recurrent
Xeloda
Administration route: Oral
Indication: Rectal Cancer Recurrent
Start date: 2009-12-15
End date: 2010-10-13
Oxaliplatin
Dosage: dosage is uncertain.
Indication: Rectal Cancer Recurrent
Start date: 2009-12-15
Erbitux
Dosage: dosage is uncertain.
Indication: Rectal Cancer Recurrent
Other drugs received by patient: Novorapid; Lantus; Pydoxal
Possible Erbitux side effects in male
Reported by a physician from Japan on 2012-04-04
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Jaundice, Bile Duct Stenosis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Irinotecan HCL
Dosage: dosage is uncertain.
Indication: Rectal Cancer Metastatic
Oxaliplatin
Dosage: dosage is uncertain.
Indication: Rectal Cancer Metastatic
Start date: 2009-12-15
Xeloda
Administration route: Oral
Indication: Rectal Cancer Metastatic
Start date: 2009-12-15
End date: 2010-10-01
Erbitux
Dosage: dosage is uncertain.
Indication: Rectal Cancer Metastatic
Other drugs received by patient: Lantus; Pydoxal; Novorapid
Possible Erbitux side effects in 79 year old male
Reported by a consumer/non-health professional from Germany on 2012-04-02
Patient: 79 year old male, weighing 62.0 kg (136.4 pounds)
Reactions: Cerebral Haemorrhage, Infusion Related Reaction
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Erbitux
Other drugs received by patient: Polaramine; Decadron; Amlodipine; Zofran
Possible Erbitux side effects in 74 year old male
Reported by a physician from Germany on 2012-03-20
Patient: 74 year old male
Reactions: Cerebrovascular Accident
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Erbitux
Dosage: last inf: 08feb2012 total inf:840mg
Indication: Lung Carcinoma Cell Type Unspecified Stage IV
Start date: 2011-07-06
End date: 2012-02-08
Erbitux
Dosage: last inf: 08feb2012 total inf:840mg
Indication: non-Small Cell Lung Cancer
Start date: 2011-07-06
End date: 2012-02-08
Possible Erbitux side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-19
Patient: male
Reactions: Laryngectomy
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Erbitux
Possible Erbitux side effects in 52 year old female
Reported by a consumer/non-health professional from Germany on 2012-03-08
Patient: 52 year old female
Reactions: Chest Pain
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cisplatin
Dosage: for 55mins 18.15-19.10 last inf on 10nov11.
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Erbitux
Dosage: last 17jan12 cancelled on 8cyc 13sep11
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Docetaxel
Dosage: intravenous infusion for 70mins 19.15-20.25 last 10nov11.
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Other drugs received by patient: Tramadol Hydrochloride; Metoclopramide; Enoxaparin Sodium; Voltaren; Granisetron Hydrochloride; Prednisolone; Levofloxacin; Calcium Carbonate; Pantoprazole; Promethazine HCL; Levothyroxine Sodium; Pentasa; Haloperidol
Possible Erbitux side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-07
Patient: male
Reactions: Laryngectomy
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Erbitux
Possible Erbitux side effects in 79 year old male
Reported by a consumer/non-health professional from Germany on 2012-03-07
Patient: 79 year old male, weighing 62.0 kg (136.4 pounds)
Reactions: Loss of Consciousness, Cerebral Haemorrhage
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Erbitux
Other drugs received by patient: Polaramine; Decadron; Zofran; Amlodipine
Possible Erbitux side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-02-26
Patient: 52 year old female
Reactions: Chest Pain
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Erbitux
Dosage: last 17jan12 cancelled on 8cyc 13sep11
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Cisplatin
Dosage: for 55mins 18.15-19.10 last inf on 10nov11.
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Docetaxel
Dosage: intravenous infusion for 70mins 19.15-20.25 last 10nov11.
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Other drugs received by patient: Pantoprazole; Levofloxacin; Levothyroxine Sodium; Voltaren; Promethazine HCL; Metoclopramide; Prednisolone; Kevatril; Haloperidol; Enoxaparin Sodium; Calcium Carbonate; Tramadol Hydrochloride; Pentasa
Possible Erbitux side effects in 52 year old female
Reported by a consumer/non-health professional from Germany on 2012-02-12
Patient: 52 year old female
Reactions: Chest Pain
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Erbitux
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
End date: 2012-01-17
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
End date: 2011-11-10
Docetaxel
Dosage: intravenous infusion
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
End date: 2011-11-10
Possible Erbitux side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-01-29
Patient: 52 year old female
Reactions: Chest Pain
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Erbitux
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Docetaxel
Indication: non-Small Cell Lung Cancer
Start date: 2011-09-06
Possible Erbitux side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-26
Patient: 59 year old male
Reactions: Dermatitis Acneiform, Skin Necrosis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Erbitux
Other drugs received by patient: Solu-Medrol; Zofran; Soludecadron; Mannitol; Cisplatin; Polaramine; Fluorouracil
Possible Erbitux side effects in male
Reported by a consumer/non-health professional from Germany on 2011-11-08
Patient: male
Reactions: Metastases To Spine
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Erbitux
|
